APPENDICEAL ADENOCARCINOMA
Clinical trials for APPENDICEAL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new APPENDICEAL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for APPENDICEAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a new immunotherapy combo tame aggressive appendiceal cancer?
Disease control Not yet recruitingThis phase II trial is testing whether combining the experimental immunotherapy drug ivonescimab with chemotherapy (paclitaxel) delivered directly into the abdomen can safely and effectively treat people with high-grade metastatic appendiceal adenocarcinoma that cannot be removed…
Matched conditions: APPENDICEAL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Experimental shot takes aim at stomach cancer spread
Disease control Not yet recruitingThis early-stage trial tests a drug called ACM-CpG, which is injected directly into the abdomen to stimulate the immune system against cancer. It includes 24 adults with colorectal or appendix cancer that has spread to the lining of the abdomen or caused fluid buildup. The main g…
Matched conditions: APPENDICEAL ADENOCARCINOMA
Phase: PHASE1 • Sponsor: Brown University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC